Ascophyllum nodosum and Fucus vesiculosus on glycemic status and on endothelial damage markers in dysglicemic patients.
Ascophyllum nodosum
Fucus vesiculosus
dysglycemia
nutraceutical
Journal
Phytotherapy research : PTR
ISSN: 1099-1573
Titre abrégé: Phytother Res
Pays: England
ID NLM: 8904486
Informations de publication
Date de publication:
Mar 2019
Mar 2019
Historique:
received:
07
07
2018
revised:
02
12
2018
accepted:
09
12
2018
pubmed:
5
2
2019
medline:
18
6
2019
entrez:
5
2
2019
Statut:
ppublish
Résumé
The aim of this study was to evaluate a nutraceutical combination containing polyphenols extracted from Ascophyllum nodosum and Fucus vesiculosus and chromium picolinate on glyemic status; secondary outcomes were considered the changes on endothelial markers. We randomized 65 dysglycemic patients to placebo or the nutraceutical agent for 6 months. We evaluated fasting plasma glucose (FPG), postprandial plasma glucose (PPG), HbA
Substances chimiques
Blood Glucose
0
Plant Extracts
0
Tumor Necrosis Factor-alpha
0
C-Reactive Protein
9007-41-4
Types de publication
Journal Article
Randomized Controlled Trial
Langues
eng
Sous-ensembles de citation
IM
Pagination
791-797Informations de copyright
© 2019 John Wiley & Sons, Ltd.